As of 2025-12-20, the EV/EBITDA ratio of Guardant Health Inc (GH) is -41.21. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. GH's latest enterprise value is 13,385.08 mil USD. GH's TTM EBITDA according to its financial statements is -324.82 mil USD. Dividing these 2 quantities gives us the above GH EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 8.5x - 12.3x | 10.0x |
| Forward P/E multiples | 8.1x - 15.7x | 10.2x |
| Fair Price | (25.68) - (35.11) | (29.55) |
| Upside | -125.7% - -135.2% | -129.6% |
| Date | EV/EBITDA |
| 2025-12-19 | -41.21 |
| 2025-12-18 | -40.16 |
| 2025-12-17 | -40.31 |
| 2025-12-16 | -41.31 |
| 2025-12-15 | -42.37 |
| 2025-12-12 | -42.13 |
| 2025-12-11 | -41.86 |
| 2025-12-10 | -42.35 |
| 2025-12-09 | -42.58 |
| 2025-12-08 | -42.96 |
| 2025-12-05 | -42.11 |
| 2025-12-04 | -44.69 |
| 2025-12-03 | -43.67 |
| 2025-12-02 | -42.85 |
| 2025-12-01 | -43.38 |
| 2025-11-28 | -44.65 |
| 2025-11-26 | -44.40 |
| 2025-11-25 | -44.80 |
| 2025-11-24 | -45.77 |
| 2025-11-21 | -43.46 |
| 2025-11-20 | -41.43 |
| 2025-11-19 | -41.13 |
| 2025-11-18 | -39.55 |
| 2025-11-17 | -39.91 |
| 2025-11-14 | -39.08 |
| 2025-11-13 | -38.98 |
| 2025-11-12 | -40.45 |
| 2025-11-11 | -40.40 |
| 2025-11-10 | -40.49 |
| 2025-11-07 | -40.01 |
| 2025-11-06 | -39.82 |
| 2025-11-05 | -39.35 |
| 2025-11-04 | -40.57 |
| 2025-11-03 | -40.88 |
| 2025-10-31 | -38.54 |
| 2025-10-30 | -38.30 |
| 2025-10-29 | -30.31 |
| 2025-10-28 | -29.24 |
| 2025-10-27 | -29.75 |
| 2025-10-24 | -30.26 |
| 2025-10-23 | -29.15 |
| 2025-10-22 | -28.63 |
| 2025-10-21 | -28.42 |
| 2025-10-20 | -29.49 |
| 2025-10-17 | -27.61 |
| 2025-10-16 | -28.41 |
| 2025-10-15 | -27.11 |
| 2025-10-14 | -26.46 |
| 2025-10-13 | -26.13 |
| 2025-10-10 | -27.12 |